CME

The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with ACCME Essentials.

Joslin Diabetes Center is the world’s preeminent diabetes clinic, diabetes research center, and provider of diabetes education. Joslin is dedicated to ensuring people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure for the disease. Founded in 1898 by Elliott P. Joslin, MD, Joslin is an independent nonprofit institution affiliated with Harvard Medical School. For more information about Joslin, call 1-800-JOSLIN-1 or visit www.joslin.org.

In 2006, Joslin was re-accredited by the ACCME and received “Accreditation with Commendation” status, the highest rating achievable by a provider of CME.

Diabetes is a condition impacting increasing numbers of people: by the year 2010, an estimated 10% of the U.S. population will be affected, and over 90% of this group will have type 2 diabetes. Effective long-term treatment interventions, as well as clinical tools to monitor disease progression and the impact of treatment, are being developed and used as part of the initiative to slow or halt the progression of type 2 diabetes and the development of complications.

For these early interventions to be successfully implemented, early identification of those at high risk for developing type 2 diabetes is needed. The clinical constellations that we currently rely on are not always accurate, and better clinical markers are needed to more effectively identify patients at increased risk of developing diabetes. Biomarker assessment systems are thus being developed for this purpose. This paradigm shift, led by this development of new methodologies and technologies, may help clinicians target people in need of early intervention more easily and effectively. The goal of this activity is to provide an overview of the current methods for identifying at-risk individuals, and to present directions that this effort might take in improving our ability to pinpoint at-risk individuals in the near future.

• Describe medical/economic impact of type 2 diabetes and its cardiovascular complications
• Discuss shortcomings of currently available methods for diagnosing type 2 diabetes and identifying people with increased cardiometabolic risk
• Identify potential components of the constellation of cardiometabolic abnormalities, including biomarkers, that can be used to improve identification of people at risk for developing type 2 diabetes
• Describe current and evolving procedures for identifying individuals who are at increased risk of developing type 2 diabetes as well as methods for their optimal use

As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds) or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

It is the policy of Joslin Diabetes Center to ensure fair balance, independence, objectivity, and scientific rigor in all activities. All faculty participating in CME activities sponsored by Joslin Diabetes Center are required to present evidence-based data, identify and reference off-label product use, and disclose all relevant financial relationships with those supporting the activity or any others whose products or services are discussed. 

See off-label statement

Joslin Diabetes Center
Professional Education
One Joslin Place
Boston, MA 02215
Contact this provider

When you have viewed all of the webcast presentations, click here to go to the Joslin Professional Education Web site and take the posttest. Before beginning the posttest, you will need to register and enter this passcode: 200801.

The activity evaluation will be available online after you have completed the posttest on the Joslin Professional Education Web site.

After you have successfully completed the post-test and evaluation on the Joslin Professional Education Web site, you will be able to print out your certificate immediately.

How to Obtain Credit:

1. Read the target audience, learning objectives, and faculty disclosures.
2. Study the educational content online.
3. Go to the Joslin Professional Education Web site at www.ProfessionalEd.joslin.org and select the online posttest for this activity. Before beginning the posttest, you will need to register and enter this passcode: 200801.
4. Physicians who receive a grade of 70% or better on the posttest and who complete the evaluation will receive immediate CME credit.
5. All other participants who receive a grade of 70% or better on the posttest and who complete the evaluation will receive a certificate of participation.